Proliferation inhibition and apoptosis induction of imatinib-resistant chronic myeloid leukemia cells via PPP2R5C down-regulation

Despite the success of imatinib and other tyrosine kinase inhibitors (TKIs), chronic myeloid leukemia (CML) remains largely incurable, and a number of CML patients die due to Abl mutation-related drug resistance and blast crisis. The aim of this study was to evaluate proliferation inhibition and apo...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Glavni autori: Shen, Qi, Liu, Sichu, Chen, Yu, Yang, Lijian, Chen, Shaohua, Wu, Xiuli, Li, Bo, Lu, Yuhong, Zhu, Kanger, Li, Yangqiu
Format: Artigo
Jezik:Inglês
Izdano: BioMed Central 2013
Teme:
Research
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC3847136/
https://ncbi.nlm.nih.gov/pubmed/24004697
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1756-8722-6-64
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items